Have you read these stories?

MHA extends guidelines for re-opening

The Centre said the current guidelines allowing various activities with up to 50% of their seating capacity will continue to be applic ...
The Economic Times
English EditionEnglish Editionहिन्दी
| 27 October, 2020, 08:30 PM IST | E-Paper


    Strides receives USFDA approval for Ethacrynic Acid Tablets

    Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food & Drug Administration (USFDA).

    Fringe brands step up phone launches to cash in on Covid-induced surge in demand

    Brands like LG, ASUS, Karbonn, Gionee, iTel, Infinix, Tecno,...

    After tablets, Hetero working on antiviral medicine Favipiravir injections

    If successful, Hetero will become the first Indian drug maker to i...

    Load More...
    The Economic Times